Mark For: NAVXPRESS™ trademark registration is intended to cover the categories of providing custom reagents for scientific and medical research and development; genetic engineering services, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools, including those based on recombinant adeno-associated viral vectors; Custom manufacturing services, namely, production for others of clinical and medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy, and therapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, including gene therapy delivery of antibody biologics, enzymes and RNA interference (RNAi).
Status
2022-06-04 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
(Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
William R. Samuels
Attorney Docket Number
101928
Timeline
2022-05-31
Application Filed
2022-06-03
Location: NEW APPLICATION PROCESSING
2022-06-03
Status: Live/Pending
2022-06-03
Status: New application will be assigned to an examining attorney approximately 6 months after filing date.
WILLIAM R. SAMUELS WARSHAW BURSTEIN, LLP 575 LEXINGTON AVENUE, 7TH FLOOR NEW YORK, NY 10022
Good, Services, and Codes
International Codes:
40
U.S. Codes:
100,103,106
International Codes:
42
U.S. Codes:
100,101
Type Code
Type
GS0421
Providing custom reagents for scientific and medical research and development; genetic engineering services, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools, including those based on recombinant adeno-associated viral vectors; Custom manufacturing services, namely, production for others of clinical and medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy, and therapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, including gene therapy delivery of antibody biologics, enzymes and RNA interference (RNAi)
Trademark Filing History
Description
Date
Proceeding Number
NEW APPLICATION ENTERED IN TRAM
2022-06-03
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
OneLook
Acronym Finder
REGENXBIO Inc.
Application
| 